These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1895044)

  • 21. The effects of slow-release verapamil on blood pressure and cardiovascular system in essential hypertension.
    Meric M; Adalet K; Erzengin F; Korkut F; Okur O; Büyüköztürk K
    J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S42-4. PubMed ID: 2475684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of ketanserin and enalapril in the treatment of mild-to-moderate essential hypertension.
    Malatino LS; Stancanelli B; Greco G; Polizzi G; Assogna G; Zanna C; Tamburino G
    Cardiovasc Drugs Ther; 1990 Jan; 4 Suppl 1():123-6. PubMed ID: 2285642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A randomized double-blind therapeutic trial of enalapril versus timed-release nifedipine in mild to moderate essential hypertension].
    Artigou JY; Benichou M; Berland J; Fressinaud P; Grollier G; Guéret P; Nguyen Cong Duc L
    Presse Med; 1990 Jan 6-13; 19(1):13-6. PubMed ID: 2137218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of labetalol versus enalapril as monotherapy in elderly patients with hypertension: results of 24-hour ambulatory blood pressure monitoring.
    Applegate WB; Borhani N; DeQuattro V; Kaihlanen PM; Oishi S; Due DL; Sirgo MA
    Am J Med; 1991 Feb; 90(2):198-205. PubMed ID: 1996588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Verapamil versus hydrochlorothiazide in the treatment of hypertension: results of long term double blind comparative trial. Verapamil versus Diuretic (VERDI) Trial Research Group.
    Holzgreve H; Distler A; Michaelis J; Philipp T; Wellek S
    BMJ; 1989 Oct; 299(6704):881-6. PubMed ID: 2510877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of lercanidipine versus hydrochlorothiazide as add-on to enalapril in diabetic populations with uncontrolled hypertension.
    Agrawal R; Marx A; Haller H
    J Hypertens; 2006 Jan; 24(1):185-92. PubMed ID: 16331117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the angiotensin II antagonist losartan with the angiotensin converting enzyme inhibitor enalapril in patients with essential hypertension.
    Tikkanen I; Omvik P; Jensen HA
    J Hypertens; 1995 Nov; 13(11):1343-51. PubMed ID: 8984133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy and safety compared with placebo and enalapril.
    Holwerda NJ; Fogari R; Angeli P; Porcellati C; Hereng C; Oddou-Stock P; Heath R; Bodin F
    J Hypertens; 1996 Sep; 14(9):1147-51. PubMed ID: 8986917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Additive effects of verapamil and enalapril in the treatment of mild to moderate hypertension.
    Levine JH; Ferdinand KC; Cargo P; Laine H; Lefkowitz M
    Am J Hypertens; 1995 May; 8(5 Pt 1):494-9. PubMed ID: 7662226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
    Luque Otero M; Martell Claros N;
    Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relationship of dose to the antihypertensive response of verapamil-sustained release in patients with mild to moderate essential hypertension. The Verapamil-SR Study Group.
    McMahon FG; Reder RF
    J Clin Pharmacol; 1989 Nov; 29(11):1003-7. PubMed ID: 2689469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Favourable interaction of calcium antagonist plus ACE inhibitor on cardiac haemodynamics in treating hypertension: rest and effort evaluation.
    Di Somma S; Carotenuto A; de Divitiis M; Paulucci A; Galderisi M; Cuocolo A; de Divitiis O
    J Hum Hypertens; 1995 Mar; 9(3):163-8. PubMed ID: 7783096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rationale for ACE inhibition in the elderly: treatment of arterial hypertension with enalapril.
    Forette F; Handfield-Jones R; Henry-Amar M; Fouchard M; Bouchacourt P; Hervy MP; Henry JF; Billaud-Mesguish E; Alexandre JM
    Gerontology; 1987; 33 Suppl 1():9-16. PubMed ID: 2831117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and influence on quality of life of enalapril as a first step treatment of hypertension.
    Chatellier G; Sassano P; Amiot AM; Corvol P; Ménard J
    Clin Exp Hypertens A; 1987; 9(2-3):513-9. PubMed ID: 3038415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Controlled study on the treatment of hypertension with verapamil in retard form].
    Belz GG; Spies G
    Z Kardiol; 1985 Aug; 74(8):453-9. PubMed ID: 3901562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lisinopril versus slow-release nifedipine in the treatment of mild to moderate hypertension: a multicentre study. The Cooperative Study Group.
    Witchitz S; Serradimigni A
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():29-33. PubMed ID: 2550643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality of life perception during antihypertensive treatment: a comparative study of bisoprolol and enalapril.
    Breed JG; Ciampricotti R; Tromp GP; Valster FA; Lageweg E; Van Bortel LM
    J Cardiovasc Pharmacol; 1992; 20(5):750-5. PubMed ID: 1280737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The efficacy and duration of action of sustained-release verapamil in essential hypertension.
    McCormack PM; Latham AN; Mee F; Atkins N; O'Brien ET; O'Malley K
    J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S34-7. PubMed ID: 2475682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new sustained-release formulation of verapamil in the treatment of hypertension.
    Midtbo KA; Hals O; Lauve O
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):125S-132S. PubMed ID: 3540222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and tolerability of trandolapril in mild to moderate hypertension--a double blind comparative clinical trial with enalapril in Indian population.
    Shankar PK; Vidyasagar S; Adiga S; Naidu MU; Usha Rani P; Rao D; Bairy KL; Nair S; Jayaprakash B; Shashikiran U; Mukhyapranaprabhu
    Indian J Physiol Pharmacol; 2006; 50(4):421-6. PubMed ID: 17402274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.